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Summary 
The microtubule-associated protein tau is predominantly localized in axons but mechanisms 
responsible for the localization of tau in the distal part of the axon are not properly 
understood. Using fluorescence in situ hybridization , we show that tau mRNA is present in 
the central and distal parts of the axon of cultured rat cortical neurons. In the distal part of the 
axon, tau mRNA is associated with granules which are distributed throughout the entire 
length of the axon, including the growth cone. We also show that tau mRNA-containing 
axonal particles are associated with the eukaryotic elongation factor 1A. The association of 
elongation factor 1A with axonal tau mRNA suggests that tau is synthesized locally in the 
axon at a long distance from the cell body. The presence of tau mRNA in the axon might be 
at least part of the process by which tau is specifically localized to the axon that may be 
disrupted in neurodegenerative conditions in which tau accumulates in the cell body. 
  
Introduction 
 
Tau is a neuronal microtubule-associated protein playing an important role in microtubule 
assembly and stability. The tau protein is predominantly localized in the axonal compartment 
over the entire length of the axon. Abnormal perikaryal accumulation of tau is a characteristic 
feature of several neurodegenerative diseases, including Alzheimer’s disease (Ballatore et al., 
2007; Gallo et al., 2007). Understanding the mechanisms responsible for the axonal 
localization of tau is therefore not only relevant to normal neuronal physiology but also to 
pathogenic mechanisms in some neurodegenerative conditions.  
The mechanisms responsible for the axonal localization of tau are not properly 
understood. Tau could be synthesized in the cell body only and transported down the axon. 
Tau can diffuse from the cell body into the axon, however diffusion is only effective over 
short distances and can only explain tau presence in the proximal part of the axon (Konzack 
et al., 2007). Over longer distances tau is, at least in part, transported bound to microtubule 
fragments moving along the axon through a dynein/actin dependent mechanism (Konzack et 
al., 2007). Another proposed mechanism to explain the specific axonal localization of tau, not 
mutually exclusive with transport of the protein on microtubules, is that tau is synthesized in 
the axon following selective transport of its mRNA. In addition to the cell body, tau mRNA 
has been observed in the proximal axon of rat primary neurons using in situ hybridization 
(Litman et al., 1993). Thus tau could be synthesized in the proximal part of the axon and 
transported further down the axon bound to microtubule fragments.  
 The targeting of specific mRNAs to subcellular compartments is a mechanism 
ensuring local synthesis of proteins. This has been well documented in dendrites, which 
allows local protein translation in particular in response to neurotransmitters or neurotrophic 
factors (Hirokawa, 2006; Martin and Zukin, 2006). RNA is transported in dendrites as large 
RNP granules. Kanai et al. (Kanai et al., 2004) isolated large RNase-sensitive granules from 
mouse brain as a binding partner of kinesin KIF5, they contained several different mRNAs 
and proteins involved in RNA-processing, including the eukaryotic elongation factor 1A 
(eEF1A). These mRNA-protein complexes were visualized in the dendrites of hippocampal 
neurons. A body of evidence has emerged showing that mRNAs are present and locally 
translated in axons in particular during elongation and in response to injury (Donnelly et al.; 
Sotelo-Silveira et al., 2006; Taylor et al., 2009; Willis et al., 2005). 
 Whether endogenous tau mRNA is present in distal axons is still an open question. In 
this study, we explored the localization of tau mRNA in the axon using fluorescence in situ 
hybridization (FISH) in primary rat cortical neurons. We show that tau mRNA is not only 
present in the cell body and proximal axon, but also in granules throughout the axon, 
including the growth cone. We also show that tau mRNA-containing axonal RNP granules 
are associated with eEF1A, suggesting that tau mRNA is translated locally in the axon. 
  
Results and Discussion 
 
RNA granules in the axon 
 
To establish the presence of RNA in the axon, primary rat cortical neurons were stained with 
the RNA-specific dye, SYTO 14. Neurons were seeded at very low density; hence individual 
neurons were easily distinguished. Axonal processes were defined by morphological 
assessment as the longest process in each neuron. Furthermore, to distinguish axons from 
dendrites, neurons were stained with an antibody against the neurofilament heavy subunit 
(NF-H), a specific axonal marker. Neurons were brightly labeled by SYTO 14 with the cell 
body staining intensely (Fig.1A). In addition, SYTO 14 labeled RNA in neuronal processes, 
dendrites as well as axons, with small granules observed along the length of the axon. To 
confirm the specificity of the staining, neurons were treated with RNases after labeling with 
SYTO 14 (Fig. 1B). Treatment with RNases reduced SYTO 14 staining in the cell body and 
completely abolished granular staining in processes thus confirming that the SYTO 14-
positive granules contained RNA.  
 
Tau mRNA is present in RNA granules in axons 
 
We next analyzed the distribution of tau mRNA in rat primary cortical neurons using FISH. 
A digoxigenin (DIG)-labeled RNA probe representing the last 400 3’ bases of the coding 
region of tau mRNA was synthesized. This sequence encodes the C- terminus of the tau 
protein, including the third and fourth microtubule-binding repeat domains, a domain not 
affected by alternative splicing and expressed in rat embryonic neurons. Using this probe, an 
intense staining for tau mRNA was obtained in cell bodies and proximal axons (Fig. 2A) 
consistent with previous studies (Litman et al., 1993).  
In addition, tau mRNA was also observed in distal parts of the axon. High magnification 
revealed a granular staining pattern with tau mRNA granules distributed along the length of 
the axon (Fig. 2B). To validate the specificity of tau mRNA staining a number of control 
conditions were used (Fig. 2C-E). Importantly, only a weak background signal was detected 
using a sense probe (Fig. 2C).  A weak background signal was also obtained when cells were 
incubated with the anti-DIG antibody only, without any RNA probe (Fig. 2D). Finally, the 
tau mRNA signal detected with the antisense probe was reduced to a weak background when 
cells were treated with RNases before the FISH procedure (Fig. 2E). Thus, endogenous tau 
mRNA is associated with granules in the axon of rat primary cortical neurons. 
These results clearly suggest that neurons target tau mRNA to distal parts of the axon, and 
are consistent with earlier studies demonstrating that tau mRNA is present as granules in 
neurite-like processes in P19 teratocarcinoma cells overexpressing tau and differentiated into 
a neuronal phenotype (Aronov et al., 2001; Aronov et al., 2002). In situ hybridization for tau 
mRNA in cultured neurons revealed the presence of tau mRNA in the proximal part of the 
axon only and not in the distal part (Litman et al., 1993). However, in this case, the detection 
method, alkaline phosphatase, was not as sensitive as fluorescence. Although we found tau 
mRNA in the axon, tau was not among the proteins synthesized in axons isolated from 
cultured adult dorsal root ganglion neurons identified in a proteomic study (Willis et al., 
2005). However a number of other cytoskeletal proteins were found in this analysis, 
including β-actin, peripherin, vimentin, that may be required for axonal growth and 
maintenance. 
  
Tau mRNA co-segregates with eEF1A 
 
Dendritic RNP granules are complexes of RNA, RNA processing proteins and transport 
proteins (Kanai et al., 2004). Among RNA-processing proteins associated with dendritic 
RNA granules, eEF1A is of particular significance due to its role in translation. The main 
function of eEF1A is to facilitate the recruitment of aminoacyl-tRNA to the A site of the 
ribosome in the elongation phase of protein synthesis. Thus the presence of eEF1A in 
dendritic RNP particles is consistent with local translation. We investigated whether eEF1A 
was present in tau mRNA granules in the axon. We first determined whether eEF1A was 
associated with RNA in the axon by combined immunostaining for eEF1A and SYTO 14 
staining. eEF1A was mainly localized in the somatodendritic compartment (Fig. 3A). 
However, eEF1A was also detected in the axon where eEF1A staining co-localized with 
SYTO 14 in granular material (Fig. 3B).  
FISH labeling for tau mRNA was performed in combination with immunostaining for 
eEF1A (Fig. 3C). Laser scanning confocal microscopy revealed a clear co-localization 
between tau mRNA and eEF1A in granular material in the proximal as well as in more distal 
parts of the axon (Fig. 3D, upper and lower panel, respectively). Both eEF1A and tau mRNA 
was also visualized in the growth cone (Fig. 3E, F), with a high density staining observed for 
tau mRNA as well as eEF1A at the leading edge of the growth cone (Fig. 3F).  
The presence of eEF1A in axonal tau mRNA-containing granules suggests that tau is 
translated locally in distal axons, including in growth cone, where translation of tau may be 
essential for growth cone motility. However, other non-canonical roles for eEF1A in RNA-
processing have been suggested, such as regulation of mRNA localization (Mateyak and 
Kinzy).  
In this study, we have demonstrated the presence of tau mRNA in granular structures 
distributed throughout the axon of primary cortical neurons. The association of the elongation 
factor, eEF1A, with axonal tau mRNA granules suggests that tau may be synthesized locally 
in the axon at a long distance from the cell body. Localization of tau mRNA in the axon 
might be at least part of the process by which tau is specifically localized to the axon. Future 
investigations will be aimed at identifying proteins associated with tau mRNA-containing 
RNPs that determine their axonal localization. Irrespective of the precise nature of these 
proteins, the results presented here are the first to show the presence of tau mRNA in distal 
axons of cultured neurons. Abnormal sorting of hyperphosphorylated tau to the 
somatodendritic compartment, where it aggregates into neurofibrillary tangles (NFTs), is a 
feature of a group of neurodegenerative diseases referred to as the tauopathies, including 
Alzheimer’s disease (AD) (Ballatore et al., 2007). Aberrant RNA processing is becoming 
increasingly associated with neurodegenerative disorders, tau mislocalization in tauopathies 
may be the consequence of mis-targeting of its mRNA to the axon.  
  
Materials and Methods 
 
Antibodies 
Sheep polyclonal anti-digoxigenin antibody was purchased from Roche Applied Science 
(West Sussex, UK); the mouse monoclonal anti-α-tubulin DM1A was from Sigma-Aldrich 
(Dorset, UK); the mouse monoclonal anti-eEF1A antibody CBP-KK1 was from Millipore 
(Durham, UK); rabbit polyclonal anti-NF-H antibody was from Enzo Life Sciences (Exeter, 
UK). 
 
Primary neuronal culture 
All culture reagents were purchased from Invitrogen Ltd (Paisley, UK), unless otherwise 
stated. Cortical neurons were prepared from embryonic day 18 Sprague Dawley rat embryos 
(Charles River, Margate, UK). Isolated cortices were treated with 0.05% trypsin-EDTA and 
dissociated into a single cell suspension using gentle trituration. Cells were cultured in 
Neurobasal medium supplemented with 2% (v/v) B27 serum-free supplement, 2mM L-
glutamine, penicillin (100 units/ml) and streptomycin (100 μg/ml) on coverslips coated with 
10 μg/ml poly-D-lysine. 3 μM cytosine arabinofuranoside (Sigma-Aldrich) was added to the 
culture medium after 3 days and neurons were cultured for up to 7 days before further 
processing. Neurons were maintained at 37˚C in a humidified atmosphere of 5 % CO2/95 % 
air. 
 
Preparation of RNA probes 
A cDNA fragment corresponding to the 3’ 400 nucleotides (899-1299) of the coding region 
of a cDNA encoding the longest isoform of rat tau (Kosik et al., 1989) was subcloned into the 
pSPT19 vector (Roche) between the AccI and EcoRI sites. In vitro transcription was 
performed with a DIG-labeled nucleotide mixture using a DIG-RNA Labeling kit (Roche) 
according to the manufacturer’s instructions. Both sense and antisense tau RNA probes were 
synthesized from the same template by using either the SP6 or the T7 promoter in the 
pSPT19 vector. 
 
Fluorescence in situ hybridization 
All steps were performed at room temperature unless otherwise stated. Neurons were washed 
at 37˚C in PBS containing 5 mM MgCl2 (PBSM) and then fixed for 15 min with 4 % (w/v) 
paraformaldehyde in PBSM (pre-warmed to 37˚C). Following fixation cells were washed 
three times in PBSM, permeabilized for 5 min with 0.1 % (v/v) Triton X-100 in PBSM, and 
then washed three times in PBSM. Before hybridization neurons were prehybridized in the 
hybridization buffer [30 % (v/v) formamide, 10 mM NaH2PO4, 10 % (v/v) dextran sulphate, 
125 µg/ml tRNA, 100 µg/ml salmon sperm DNA (denatured by heating at 95˚C for 3 min 
before use), 2× saline-sodium citrate (SSC), 10 mM vanadyl ribonuclease and 1× Denhardt’s 
solution] for 2 hours at 50˚C. Hybridization was then performed using 100 ng of denatured 
RNA probe per coverslip in hybridization buffer overnight at 50˚C. Following hybridization 
cells were washed twice in 30 % (v/v) formamide and 2× SSC followed by three times in 2× 
SSC for 15 min each at 50˚C. Cells were incubated with primary antibodies in 1 % (w/v) 
BSA in PBSM overnight at 4˚C. Following three washes in PBSM, cells were incubated with 
appropriate secondary antibodies in 1 % (w/v) BSA in PBSM for 1 hour, followed by three 
washes in PBSM. Coverslips were mounted in fluorescence mounting medium 
(DakoCytomation) and slides were viewed under a Zeiss LSM 510 META laser scanning 
confocal microscope or a Zeiss Axioskop fluorescence microscope with appropriate filters 
and imaged using LSM 510 imaging software or Metamorph software, respectively. For 
RNase treatment neurons were incubated with RNase A (10 µg/ml) and RNase T1 (1000 
units/ml) in PBSM for 30 min at 37˚C after fixation and permeabilization, but prior to RNA 
hybridization. 
 
RNA staining  
Neurons were incubated with 500 nM SYTO 14 dye (Molecular Probes) diluted in culture 
medium for 15 min at 37˚C and washed twice in the same medium before fixation with 4 % 
(w/v) paraformaldehyde in PBS for 15 min. After fixation, neurons were washed three times 
in PBS and permeabilized in 0.1 % (v/v) Triton X-100 for 5 min. After three more washes in 
PBS, cells were incubated with 5 % (w/v) BSA in PBS for 30-60 min, and then incubated 
with primary antibodies in the same solution for 1 hour. After three additional washes in PBS 
cells were incubated with appropriate secondary antibodies in 5 % (w/v) BSA in PBS for 1 
hour in the dark, followed by three washes in PBS. In some cases fixed and permeabilized 
neurons were treated with RNase A (10 µg/ml) and RNase T1 (1000 units/ml) in PBS for 30 
min at 37˚C before proceeding to immunostaining. 
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Figure legends 
 
Figure 1. Presence of RNA granules in axons. Rat primary cortical neurons were stained 
for RNA using SYTO 14 before immunostaining. (A) Axons were visualized by 
immunostaining using an NF-H antibody. RNA is present in granules in neuronal processes 
with RNA granules observed along the length of the axon (arrows). (B) Treatment with 
RNase A and RNase T1 abolishes SYTO 14 staining. Scale bars, 20 μm.  
 
Figure 2. Tau mRNA is present in RNA granules in axons. Rat primary cortical neurons 
were stained for tau mRNA by FISH using an antisense DIG-labeled tau mRNA probe and 
subsequently immunostained using anti-DIG and anti--tubulin antibodies, the latter to 
visualize the outline of the cells. (A) tau mRNA is localized to the somatodendritic 
compartment as well as the axon (arrow). (B) Higher magnification image of the boxed 
region the axon in A. A granular staining pattern of tau mRNA is observed in the axon 
(arrows). (C) FISH was performed using the sense DIG-labeled tau mRNA probe. (D) No 
RNA probe was used during FISH, only antibodies. (E) Fixed and permeabilized neurons 
were treated with RNase A and RNase T1 before FISH using the antisense tau mRNA probe. 
No DIG signal was detected in any of the control conditions. Scale bars, (A, C-E) 20 μm; (B) 
5 μm. 
 
Figure 3. Tau mRNA colocalizes with eEF1A in axons. Rat primary cortical neurons were 
stained for RNA using SYTO 14 before immunostaining. (A) eEF1A is localized to the 
somatodendritic compartment as well as the axon (white arrow). (B) Higher magnification 
images of the boxed region of the axon in (A). A granular staining pattern of eEF1A is 
observed which colocalizes with SYTO 14-positive RNA granules (arrows). Neurons were 
stained for tau mRNA using FISH and subsequently immunostained using anti-DIG and anti-
eEF1A antibodies (C, D). (D) Higher magnification images of boxed regions of the proximal 
and distal axon of the neuron in (C). Tau mRNA co-localizes with eEF1A in a granular 
staining pattern in both the proximal and distal axon (arrows). (E, F) Tau mRNA also 
colocalizes with eEF1A in growth cones (arrows), enlarged in (F). Scale bars, (A, C) 20 μm; 
(B, D, E) 10 μm; (F) 5 μm. 
   
  
 
 
 
